Cardiometabolic risk in patients with uncomplicated essential arterial hypertension
Keywords:
cardiometabolic risk, essential hypertension, cardiovascular risk, metabolic syndrome.Abstract
Introduction: Cardiometabolic risk assessment in patients with essential arterial hypertension is vital and a diagnostic challenge.
Objective: To evaluate the behavior of cardiometabolic risk in patients with uncomplicated essential hypertension.
Methods: A descriptive, cross-sectional study was carried out in 100 hypertensive patients without target organ damage who underwent clinical history, glycemia, glycosylated hemoglobin, lipidogram and uric acid. They were correlated with body mass index, time of evolution of arterial hypertension and global cardiovascular risk.
Results: Of the patients, 56 % were men, 31 % were smokers, 83 % were overweight and obese, 86 % were sedentary, 71 % did not have a healthy diet and 53 % had been hypertensive for more than 5 years. In the obese, a significant relationship was found with abdominal circumference (110.9±8.9, p=0.000), triglycerides (1.8±0.9, p=0.000) and uric acid (374±100.7, p=0.001). Age (62.9±7.8, p=0.000), systolic blood pressure (151.6±15.6, p=0.021), lower HDL (0.9±0.3, p=0.000) and uric acid (349, 3±115.3, p=0.015) were significantly related to high cardiovascular risk.
Conclusions: The results demonstrated the value of clinical parameters such as age, abdominal circumference, body mass index and systolic blood pressure, as well as metabolic parameters such as triglycerides, HDL and uric acid in the evaluation of cardiometabolic risk and its relationship with cardiovascular risk in hypertensive patients.
cardiometabolic risk; essential hypertension; cardiovascular risk; metabolic syndrome.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
